0002122464-26-000008.txt : 20260529 0002122464-26-000008.hdr.sgml : 20260529 20260529103835 ACCESSION NUMBER: 0002122464-26-000008 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260529 DATE AS OF CHANGE: 20260529 EFFECTIVENESS DATE: 20260529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMAGINOSTICS, INC. CENTRAL INDEX KEY: 0002122464 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-585579 FILM NUMBER: 261040450 BUSINESS ADDRESS: STREET 1: C/O GUIDEWELL INNOVATION CENTER STREET 2: 6555 SANGER RD, SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32827 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: C/O GUIDEWELL INNOVATION CENTER STREET 2: 6555 SANGER RD, SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32827 D 1 primary_doc.xml X0708 D LIVE 0002122464 IMAGINOSTICS, INC. C/O GUIDEWILL INNOVATION CENTER 6555 SANGER RD. SUITE 100 ORLANDO FL FLORIDA 32827 000-000-0000 DELAWARE None None Corporation true VALERIE AIMEE GHARAGOUZLOO C/O GUIDEWELL INNOVATION CENTER 6555 SANGER RD. SUITE 100 ORLANDO FL FLORIDA 32827 Executive Officer Director Promoter CODI GHARAGOUZLOO C/O GUIDEWELL INNOVATION CENTER 6555 SANGER RD. SUITE 100 ORLANDO FL FLORIDA 32827 Executive Officer Director Promoter WILLIAM SCOTT HOGE C/O GUIDEWELL INNOVATION CENTER 6555 SANGER RD. SUITE 100 ORLANDO FL FLORIDA 32827 Executive Officer Biotechnology Decline to Disclose 06b false 2026-05-14 true true true true true These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer,typically preferred stock,upon the occurrence of specified triggering events including future financingroundS. false 0 Indefinite 40000 Indefinite false 1 0 0 0 false IMAGINOSTICS, INC. Valerie Gharagouzloo Valerie Gharagouzloo CEO 2026-05-29